---
title: Inhalation & Nasal Dosage Manufacturing CDMOs
path: /services/inhalation-dosage-manufacturing
companies_count: 16
---

# Inhalation & Nasal Dosage Manufacturing CDMOs

16 published CDMOs match Inhalation & Nasal Dosage Manufacturing.

Locations in this set include United States, France, China, India, United Kingdom, and Netherlands.

Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Biologics (Monoclonal Antibodies), Gene Therapy, and Antibody-Drug Conjugate (ADC).

## Matching companies

- [Akums Drugs and Pharmaceuticals Ltd.](/companies/akums)
  - India's largest CDMO with 15+ state-of-the-art facilities and 30% domestic market share, manufacturing 4,100+ formulations across tablets, capsules, injectables, APIs, and specialty dosage forms under WHO-GMP, USFDA, EU-GMP, and TGA compliance.
- [Ardena](/companies/ardena)
  - Ardena is an integrated CDMO and bioanalytical CRO specializing in advanced drug product development, nanomedicine, and bioanalysis for complex molecules including poorly soluble compounds, highly potent APIs, and controlled substances.
- [Bend Bioscience](/companies/bend-bioscience)
  - U.S. pharmaceutical CDMO offering design, development, and manufacturing of oral solid and liquid dosage forms, from early formulation to commercial-scale production across three domestic locations.
- [Catalent](/companies/catalent)
  - Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.
- [CordenPharma](/companies/cordenpharma)
  - Full-service CDMO offering cGMP development and manufacturing of APIs, lipid excipients, drug products, injectables, peptides, LNPs, oligonucleotides, and oral solid dose across 10 facilities in 6 countries with 3000+ employees.
- [Delpharm](/companies/delpharm)
  - Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually.
- [Ethypharm](/companies/ethypharm)
  - Ethypharm is a leading mid-size international specialty pharmaceutical company with strong European roots.
- [Experic](/companies/expericservices)
  - Specialist powder-handling CDMO offering clinical trial supply, development, manufacturing, and packaging services for pharmaceutical products.
- [Hovione](/companies/hovione)
  - Specialist integrated CDMO with over 60 years of experience in contract development and manufacturing for pharmaceutical customers, supporting both new and off-patent drug programs.
- [Kindeva Drug Delivery](/companies/kindevadd)
  - Purpose-driven CDMO specializing in injectable, inhalation, and dermal drug delivery with 155,000+ sq. ft. of aseptic operations and fill-finish capabilities.
- [Lupin Limited](/companies/lupin)
  - Global pharmaceutical manufacturer with robust quality systems aligned to US FDA, UK MHRA, and EU GMP standards; operates diversified manufacturing across generics, complex formulations, and specialty segments with advanced automation and digital quality infrastructure.
- [Medpharm](/companies/medpharm)
  - Specialized CDMO for topical, transdermal, and transepithelial drug products offering formulation development, analytical testing, process scale-up, and GMP manufacturing from early development through commercialization.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Siegfried Holding](/companies/siegfried)
  - Global CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [Unither Pharmaceuticals](/companies/unither-pharma)
  - Global CDMO specializing in sterile and non-sterile liquid manufacturing, including Blow-Fill-Seal (BFS) single-dose technology with over 5 billion annual capacity, plus formulation development, analytical services, and ophthalmic expertise across six production sites.